Sanara MedTech (SMTI) Profit After Tax (2010 - 2026)

Sanara MedTech has reported Profit After Tax for 16 years, with the latest figure at $458957.0 in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 113.01% year-over-year to $458957.0; the trailing twelve-month figure through Mar 2026 stood at -$33.6 million (down 100.85% YoY), and the FY2025 full-year result was -$37.6 million, down 288.66% from the prior year.
• Profit After Tax for Q1 2026 stood at $458957.0, up from -$1.6 million in the prior quarter.
• The five-year high for Profit After Tax was $756914.0 in Q2 2022, with the low at -$30.4 million in Q3 2025.
• Historically, Profit After Tax has averaged -$3.8 million across 5 years, with a median of -$1.8 million in 2024.
• Annual changes were most pronounced in 2022 — Profit After Tax jumped 162.76% — and 2025, when it plunged 1747722.3%.
• Sanara MedTech's Profit After Tax stood at -$4.0 million in 2022, then surged by 93.45% to -$262444.0 in 2023, then sank by 3581.29% to -$9.7 million in 2024, then soared by 83.34% to -$1.6 million in 2025, then surged by 128.51% to $458957.0 in 2026.
• The last three Profit After Tax figures came in at $458957.0 (Q1 2026), -$1.6 million (Q4 2025), and -$30.4 million (Q3 2025), per Business Quant data.